Randomized Controlled Trial of Awake Transnasal Laser‐Assisted Surgery for Benign Laryngeal Lesions
The Laryngoscope · 2024
DOI: 10.1002/lary.31481 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Laryngoscope, 2024. Verfasst von Aurora Ka Yue Tam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Laser Therapy, Laryngeal Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To compare functional and cost‐effectiveness of awake transnasal laser assisted‐surgery versus microlaryngeal surgery for benign laryngeal lesions.
Methods
This was a prospective non‐inferiority randomized controlled trial conducted from May 2021 to December 2022 at two tertiary referral hospitals in Hong Kong. Patients were block‐randomized to receive either awake transnasal laser‐assisted surgery or microlaryngeal surgery, with post‐operative follow‐up in a multidisciplinary voice clinic for 1‐year. Primary outcome was Voice Handicap Index (VHI‐30). Secondary outcomes included operation time, complications, length of stay, peri‐operative discomfort, recurrence, and medical costs.
Results
Sixty‐one patients were randomized to either awake transnasal laser‐assisted surgery ( n = 30) and microlaryngeal surgery ( n = 31). Both groups had comparable demographics and laryngeal pathologies. Both groups showed significant improvement of VHI‐30 score over time and had comparable post‐operative VHI‐30. Awake transnasal laser‐assisted surgery group had a significantly shorter length of stay (0.5 vs. 1 day) and less throat discomfort (2 vs. 4) compared to microlaryngeal surgery group. Intraoperative complications were more common in microlaryngeal surgery group (14.3% vs. 0%). Otherwise, both groups had similar operative time and recurrence rate. Cost‐analysis showed a significantly lower hospital cost for awake transnasal laser‐assisted surgery (USD 3090) compared to microlaryngeal surgery group (USD 5120).
Conclusion
Awake transnasal laser‐assisted surgery was safe, functionally non‐inferior, as measured by VHI‐30, to microlaryngeal surgery in managing benign laryngeal lesions, while superior to microlaryngeal surgery in peri‐operative discomfort and medical costs. Level of Evidence 2 Laryngoscope , 134:3732–3740, 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China.
- The Institute of Human Communicative Research, The Chinese University of Hong Kong, Hong Kong SAR, China.
ORCID-Profile: Aurora Ka Yue Tam, Jason Ying Kuen Chan, Thomas Law
Zitieren
APA
Tam, A. K. Y., Leung, N. M. W., Lee, S. K. J., Wei, Y., Hu, Y., Chan, J. Y. K., & Law, T. (2024). Randomized Controlled Trial of Awake Transnasal Laser‐Assisted Surgery for Benign Laryngeal Lesions. The Laryngoscope. https://doi.org/10.1002/lary.31481
Vancouver
Tam AKY, Leung NMW, Lee SKJ, Wei Y, Hu Y, Chan JYK, et al. Randomized Controlled Trial of Awake Transnasal Laser‐Assisted Surgery for Benign Laryngeal Lesions. The Laryngoscope. 2024. doi:10.1002/lary.31481
BibTeX
@article{Tam2024,
author = {Tam, Aurora Ka Yue and Leung, Natalie Moon Wah and Lee, Shui Kwong John and Wei, Yifeng and Hu, Yunyi and Chan, Jason Ying Kuen and Law, Thomas},
title = {Randomized Controlled Trial of Awake Transnasal Laser‐Assisted Surgery for Benign Laryngeal Lesions},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.31481}
}
EUVIMED